MNX Global Logistics has announced the opening of a 1300sqm dedicated supply chain and logistics facility in Amsterdam, the Netherlands, located just outside of Amsterdam Airport Schiphol.
According to MNX, the HACCP and GDP compliant facility has validated temperature-controlled supply chain capabilities and will serve as the operations and warehousing hub for its Life Sciences and Medical Device customers throughout Europe.
“The demand for our services particularly in biologics, cold chain and medical devices logistics in the EMEA region has been tremendous and we have seen double digit growth in the past 12 months,” said Paul J. Martins, MNX CEO and President.
“Our investment in this new facility in Amsterdam is testament to MNX and our private equity partner, The Riverside Company’s commitment to meet the needs and exceed the expectations of our customers.”
The facility boasts -20°C, 2-8°C and 18°C temperature controlled storage with 24/7 monitoring and back-up and security systems.